ダウンロード数: 536
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
66_4_121.pdf | 821.99 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 大澤, 華織 | ja |
dc.contributor.author | 柚原, 一哉 | ja |
dc.contributor.author | 小鷹, 博人 | ja |
dc.contributor.author | 加藤, 大貴 | ja |
dc.contributor.author | 高井, 学 | ja |
dc.contributor.author | 飯沼, 光司 | ja |
dc.contributor.author | 中根, 慶太 | ja |
dc.contributor.author | 岡本, 清尚 | ja |
dc.contributor.author | 古家, 琢也 | ja |
dc.contributor.alternative | Ozawa, Kaori | en |
dc.contributor.alternative | Yuhara, Kazuya | en |
dc.contributor.alternative | Kotaka, Hiroto | en |
dc.contributor.alternative | Kato, Daiki | en |
dc.contributor.alternative | Takai, Manabu | en |
dc.contributor.alternative | Iinuma, Koji | en |
dc.contributor.alternative | Nakane, Keita | en |
dc.contributor.alternative | Okamoto, Kiyohisa | en |
dc.contributor.alternative | Koie, Takuya | en |
dc.contributor.transcription | オオザワ, カオリ | ja-Kana |
dc.contributor.transcription | ユハラ, カズヤ | ja-Kana |
dc.contributor.transcription | コタカ, ヒロト | ja-Kana |
dc.contributor.transcription | カトウ, ダイキ | ja-Kana |
dc.contributor.transcription | タカイ, マナブ | ja-Kana |
dc.contributor.transcription | イイヌマ, コウジ | ja-Kana |
dc.contributor.transcription | ナカネ, ケイタ | ja-Kana |
dc.contributor.transcription | オカモト, キヨヒサ | ja-Kana |
dc.contributor.transcription | コイエ, タクヤ | ja-Kana |
dc.date.accessioned | 2020-06-02T23:46:48Z | - |
dc.date.available | 2020-06-02T23:46:48Z | - |
dc.date.issued | 2020-04-30 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/251052 | - |
dc.description.abstract | A 68-year-old man was diagnosed with prostate cancer (initial serum prostate specific antigen [PSA] 389 ng/ml, stage cT4N1M1c, Gleason score 5+4), and androgen deprivation therapy was initiated. Despite the low serum PSA level, he developed postrenal acute kidney failure 4 years later, with progression of prostate cancer and liver and lung metastases. Serum levels of neuron-specific enolase and pro-gastrinreleasing peptide (tumor markers) were elevated. He underwent re-biopsy of the prostate, and histopathological examination revealed small cell carcinoma. He was initially treated with carboplatin and etoposide therapy. Liver metastases showed partial remission, and serum tumor marker levels were temporarily reduced. However, disease progression was observed after 4 chemotherapy cycles, and he was then treated with an 8-cycle course of amrubicin. Metastases showed shrinkage, and serum tumor marker levels were reduced after 2 chemotherapy cycles. Tumor enlargement recurred after 8 cycles, and the patient is being treated with palliative therapy. Amrubicin therapy may be effective in the treatment of small cell carcinoma of the prostate. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.rights | 許諾条件により本文は2021/05/01に公開 | ja |
dc.subject | Prostate cancer | en |
dc.subject | Small cell carcinoma of the prostate | en |
dc.subject | Amrubicin | en |
dc.subject.ndc | 494.9 | - |
dc.title | 二次治療としてのアムルビシンが効果を示した前立腺小細胞癌の1例 | ja |
dc.title.alternative | The Efficacy of Amrubicin Therapy as a Second Line Treatment in Patients with Small Cell Carcinoma of the Prostate : A Case Report | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 66 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 121 | - |
dc.identifier.epage | 125 | - |
dc.textversion | publisher | - |
dc.sortkey | 03 | - |
dc.address | 高山赤十字病院泌尿器科 | ja |
dc.address | 高山赤十字病院泌尿器科 | ja |
dc.address | 高山赤十字病院泌尿器科 | ja |
dc.address | 岐阜大学大学院医学系研究科病態制御学講座泌尿器科学分野 | ja |
dc.address | 岐阜大学大学院医学系研究科病態制御学講座泌尿器科学分野 | ja |
dc.address | 岐阜大学大学院医学系研究科病態制御学講座泌尿器科学分野 | ja |
dc.address | 岐阜大学大学院医学系研究科病態制御学講座泌尿器科学分野 | ja |
dc.address | 高山赤十字病院病理診断科 | ja |
dc.address | 岐阜大学大学院医学系研究科病態制御学講座泌尿器科学分野 | ja |
dc.address.alternative | The Department of Urology, Takayama Red Cross Hospital | en |
dc.address.alternative | The Department of Urology, Takayama Red Cross Hospital | en |
dc.address.alternative | The Department of Urology, Takayama Red Cross Hospital | en |
dc.address.alternative | The Department of Urology, Gifu University Graduate School of Medicine | en |
dc.address.alternative | The Department of Urology, Gifu University Graduate School of Medicine | en |
dc.address.alternative | The Department of Urology, Gifu University Graduate School of Medicine | en |
dc.address.alternative | The Department of Urology, Gifu University Graduate School of Medicine | en |
dc.address.alternative | The Department of Diagnostic Pathology, Takayama Red Cross Hospital | en |
dc.address.alternative | The Department of Urology, Gifu University Graduate School of Medicine | en |
dc.identifier.pmid | 32483946 | - |
dc.identifier.selfDOI | 10.14989/ActaUrolJap_66_4_121 | - |
dcterms.accessRights | open access | - |
datacite.date.available | 2021-05-01 | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.66 No.4 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。